Swiss Biotech Report 2020: 1.2 billion for Swiss biotech companies
- In 2019, 1.2 billion Swiss Francs were invested in private and public biotech companies
- Gene therapy, artificial intelligence, and the production of advanced biologics developed into complementary strengths
- Licensing agreements and collaborations increased revenue
- The Swiss biotech ecosystem ha…








